Evidence map›Paper›PMID 29414793›Full record

ArticleThe Journal of biological chemistry2018

High-throughput screen for inhibitors of protein-protein interactions in a reconstituted heat shock protein 70 (Hsp70) complex.

Isabelle R Taylor, Bryan M Dunyak, Tomoko Komiyama, Hao Shao, Xu Ran, Victoria A Assimon, Chakrapani Kalyanaraman, Jennifer N Rauch, Matthew P Jacobson, Erik R P Zuiderweg and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. A missense mutation in theFrontiers in neuroscience · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Heat Shock Proteins as Targets for Novel Antimalarial Drug Discovery.Advances in experimental medicine and biology · 2021
    Article
  11. Review
  12. Review
  13. Chemical Biology Framework to Illuminate Proteostasis.Annual review of biochemistry · 2020
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Isabelle R TaylorFrom the Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158 and.
Bryan M DunyakFrom the Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158 and.
Tomoko Komiyamathe Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109.
Hao ShaoFrom the Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158 and.
Xu RanFrom the Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158 and.
Victoria A AssimonFrom the Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158 and.
Chakrapani KalyanaramanFrom the Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158 and.
Jennifer N RauchFrom the Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158 and.
Matthew P JacobsonFrom the Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158 and.
Erik R P Zuiderwegthe Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109.
Jason E GestwickiFrom the Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158 and jason.gestwicki@ucsf.edu.
University of California, San Francisco · USUniversity of Michigan–Ann Arbor · US

Funding

Molecular Chaperones and Small MoleculesR01NS059690 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jason E Gestwicki · 2008 to 2026
$7.9M
RESEARCH TRAINING IN CHEMISTRY AND CHEMICAL BIOLOGYT32GM064337 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIK, CHARLES SCOTT · 2002 to 2021
$7.8M
NIGMS NIH HHS T32 GM064337NINDS NIH HHS R01 NS059690
6 · The paper itself

Abstract

Protein-protein interactions (PPIs) are an important category of putative drug targets. Improvements in high-throughput screening (HTS) have significantly accelerated the discovery of inhibitors for some categories of PPIs. However, methods suitable for screening multiprotein complexes (

Indexed as

Drug DiscoveryHigh-Throughput Screening AssaysAdaptor Proteins, Signal TransducingAdenosine TriphosphatasesApoptosis Regulatory ProteinsBinding SitesCrystallography, X-RayDrug Evaluation, PreclinicalHSP40 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsHumansMultiprotein ComplexesPharmaceutical PreparationsProtein BindingProtein Interaction MapsAdaptor Proteins, Signal TransducingAdenosine TriphosphatasesApoptosis Regulatory ProteinsBAG3 protein, humanDNAJA2 protein, humanHSP40 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsMultiprotein ComplexesPharmaceutical Preparationschemical biologyhigh-throughput screening (HTS)Hsp70, heat shock proteininhibition mechanisminhibitormolecular chaperoneprotein complexprotein–protein interaction

Identifiers

PMID29414793
PMCPMC5857975
OpenAlexW2786095341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.